Results 191 to 200 of about 60,705 (268)

Safety and Clinical Outcomes of High‐ Versus Low‐Dose Oral Peanut Immunotherapy in Polish Children With Peanut Allergy

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To compare safety and clinical outcomes of two different oral immunotherapy (OIT) maintenance doses (150 mg vs. 300 mg) of peanut protein in children with peanut allergy. Methods This prospective study enrolled 44 children aged 4–17 years with confirmed peanut allergy.
Klementyna Łyżwa   +4 more
wiley   +1 more source

Gene Expression Patterns Regulating Peanut Reproductive Phenology. [PDF]

open access: yesPlant Direct
Cardon CH   +5 more
europepmc   +1 more source

Diverging in Vivo Immune Response Patterns After Oral Food Challenge in Peanut Allergic Adults

open access: yesClinical &Experimental Allergy, EarlyView.
After the oral food challenge, peanut (PN)‐allergic adults were monitored over 4 weeks, which revealed diverging immune response patterns, with strong responders (SR) exhibiting heightened Ara h 2+ B cell expansion, PN sIgE induction and increasing PN‐specific Tconv. Weak responders (WR) had more activated PN‐specific Tregs.
Florent Fauchère   +7 more
wiley   +1 more source

IgE-Mediated Legume Allergy in Children: Insights from a Single-Center Experience in Italy. [PDF]

open access: yesNutrients
Serra B   +11 more
europepmc   +1 more source

Peanut Oral Immunotherapy in Children: An Italian Single-Center Retrospective Cohort Study. [PDF]

open access: yesNutrients
Pessina B   +11 more
europepmc   +1 more source

Big peanuts

open access: yesTijdschrift voor het Economisch Onderwijs, 2011
van den Assem, M.J., van Dolder, Dennie
openaire   +2 more sources

Emerging Paediatric Uses of Dupilumab Beyond Approvals

open access: yesClinical &Experimental Allergy, EarlyView.
Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy